Esophageal Cancer Stage IVB

Reviewed by Oncology Team, HealOnco | Last updated: 2026-04

Median OS: 6–12 months with treatment

5-year survival rate

Stage IVB

M1 (distant metastases). Spread to distant organs (liver, lung, bone, brain, peritoneum).

What Stage IVB Means

M1 (distant metastases). Spread to distant organs (liver, lung, bone, brain, peritoneum).

Treatment Approach for Stage IVB

Palliative chemotherapy (FOLFOX, carboplatin-gemcitabine) or immunotherapy (nivolumab, pembrolizumab). Clinical trials considered. Endoscopic/radiologic symptom management.

Survival Rates and Prognosis

The 5-year survival rate for esophageal cancer at Stage IVB is approximately Median OS: 6–12 months with treatment. Survival rates are statistical averages drawn from large patient populations and may not reflect your individual outcome. Factors that influence your specific prognosis include your age, overall health, tumour biology, and how well the cancer responds to treatment.

Important: These numbers are drawn from historical data. Newer treatments available today may improve outcomes beyond what published statistics show. Discuss your individual prognosis with your oncologist.

How Other Stages Compare

Stage	5-Year Survival	Treatment
Stage I	5-year survival: 40–50%	Endoscopic resection if T1a, N0. Surgery (esophagectomy) if T1b–2….
Stage IIA	5-year survival: 25–35%	Surgery with potential neoadjuvant chemotherapy/RT. Neoadjuvant CROSS protocol…
Stage IIB	5-year survival: 20–30%	Neoadjuvant chemotherapy/RT followed by esophagectomy. Consider induction…
Stage IIIA	5-year survival: 15–25%	Neoadjuvant CROSS protocol (carboplatin + paclitaxel + 50.4 Gy RT) followed by…
Stage IIIB	5-year survival: 10–20%	Neoadjuvant CRT with 50.4–60 Gy. Surgery if resectable post-treatment….
Stage IIIC	5-year survival: <10%	Palliative CRT or chemotherapy. Supportive care and symptom management…
Stage IVA	5-year survival: <5%	Palliative chemotherapy (FOLFOX or platinum-fluorouracil). Endoscopic stent for…